GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
admin GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read MoreAsthma
GSK says U.S. FDA approves Boostrix for immunization during pregnancy
GSK PLC GSK, -0.10% said Monday that the U.S. Food and Drug Administration has approved…
Read More